Koxma-CC Syrup is a multi-ingredient pharmaceutical formulation containing Ambroxol (30mg), Cetirizine (5mg), Dextromethorphan Hydrobromide (15mg), and Phenylephrine (10mg) per dose, designed for the symptomatic relief of respiratory tract conditions. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of mucus, thereby improving airway patency. Cetirizine, a second-generation antihistamine, provides effective relief from allergic symptoms such as rhinorrhea, sneezing, and nasal congestion by selectively inhibiting peripheral H1 receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive, suppressing the cough reflex without causing sedation. Phenylephrine, a sympathomimetic decongestant, constricts nasal blood vessels, reducing mucosal edema and nasal congestion. The combination of these agents makes Koxma-CC Syrup suitable for managing cough, cold, allergic rhinitis, and other upper respiratory tract infections characterized by excessive mucus production, cough, and nasal congestion. It is recommended to use this medication under medical supervision, considering potential contraindications such as hypertension, hypersensitivity, or concurrent use of monoamine oxidase inhibitors. Dosage should be adhered to as per prescribing information to minimize adverse effects and ensure therapeutic efficacy.